Loading
Hyphens Pharma International Limited Stock: price and insider trades · Singapore
2 insiders bought €28k of shares over the last 90 days, the latest by Lim See Wah, filed 22 Oct 2026.
Cluster: 2 buyers in 30 daysHyphens Pharma International Limited: what insiders have been doing
Hyphens Pharma International Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SGX. Over the twelve months to 23 October 2026, 12 filings were filed, from 4 insiders.
The flow runs one way only: 3 insiders bought (11 purchases totalling €200k) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Lim See Wah filed the largest purchase, €58k, on 21 May 2026. Among those who bought: 3 chief executives.
The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 22 October 2026, 2 days ago. Between a trade and the moment it shows up on SGX, the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public.
Across the 394 companies tracked on its exchange, the median is 6 filings; at 12 filings, this issuer sits above that mark. The full history, which starts in 2018, counts 22 purchases against 10 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at EssilorLuxottica and Dynavox Group AB. This summary is built from SGX disclosures alone and does not predict where the share price will go.
Insider Decl.
44
Thresholds
n/a
Buy Volume
€13M
22 ops. · all time
Sell Volume
€9M
10 ops. · all time
Who traded when
BuySaleTan Kia King8 buys
Lim See Wah7 buys
Chan Kiat1 buy
Since the insiders bought
- +10.6%Entry SGD 0.33 · Close 22 Oct 2026 SGD 0.37
- +11.1%Entry SGD 0.31 · Close at T+90 SGD 0.35
- +3.2%Entry SGD 0.31 · Close at T+90 SGD 0.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Hyphens Pharma International Limited Strong Buy (bullish), based on 1 analysts. Average price target: SGD 0.46.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,747 of 26,289 companies
65.9
score / 100
Value70
Quality62
FCF yld16%
Earn yld5.4%
EV/EBITDA10.3x
ROE13%
Gross mgn41%
Net mgn3.3%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SGD 0.37
Analyst consensus
1 analystsStrong buy
SGD 0.46Target SGD 0.46(+24%)SGD 0.46
Income statement
RevenueSGD 177.4M
Gross profitSGD 72.2M41% margin
EBITDASGD 11.4M6% margin
Net incomeSGD 5.8M4.8% margin
Valuation
PER (trailing)12.3x
PER (forward)8.7x
P/Book1.7x
Beta0.22
Balance sheet & cash
Market capSGD 114.3M
Total debtSGD 9.4M
Free Cash FlowSGD 17.5M
Debt / Equity17%
Profitability & ownership
ROE13.0%
ROA7.2%
% insiders78.6%
% institutions0.9%
Last declaration on 22 October 2026
Declarations44 total
60,000 shares@ SGD 0.36ShareSGX-STISIN SG1EE4000006SGX:4BW0J6PDSLQSRFCQ
Canonical exit: 19 Jan 2027 (T+90)
20,000 shares@ SGD 0.3650.0065% mcap100.0% of flowShareSGX-STISIN SG1EE4000006SGX:YESJUZQWC2E5M48N
Canonical exit: 13 Jan 2027 (T+90)
30,000 shares@ SGD 0.3650.0097% mcap100.0% of flowShareSGX-STISIN SG1EE4000006SGX:24U1TRCDGVDLNG4O
Canonical exit: 28 Dec 2026 (T+90)
ShareSGX-STSGX:S42983PDNQ94SVRT
46,400 shares@ SGD 0.3250.2% of flowShareSGX-STISIN SG1EE4000006SGX:ZOUO89JBM8LRMTM0
Canonical exit: 31 Aug 2026 (T+90)
270,000 shares@ SGD 0.321.1% of flowShareSGX-STISIN SG1EE4000006SGX:KFMMNAZZ2VKF0EEN
Canonical exit: 18 Aug 2026 (T+90)
50,000 shares@ SGD 0.3270.2% of flowShareSGX-STISIN SG1EE4000006SGX:TGH6FT1M1JUZDWP4
Canonical exit: 16 Aug 2026 (T+90)
160,000 shares@ SGD 0.3350.7% of flowShareSGX-STISIN SG1EE4000006SGX:II0B70Q523ASTX46
Canonical exit: 20 Jul 2026 (T+90)
40,000 shares@ SGD 0.32960.2% of flowShareSGX-STISIN SG1EE4000006SGX:CJBSWFB9YN8O9TGR
Canonical exit: 19 Jul 2026 (T+90)
30,000 shares@ SGD 0.3127.9% of flowShareSGX-STISIN SG1EE4000006SGX:514TWMN3SF1WER21
Canonical exit: 21 Jun 2026 (T+90)
150,000 shares@ SGD 0.331.6% of flowShareSGX-STISIN SG1EE4000006SGX:CAW96DJR4JID95U4
Canonical exit: 31 May 2026 (T+90)
40,000 shares@ SGD 0.3350.4% of flowShareSGX-STISIN SG1EE4000006SGX:X0PWLF12DUYVQH5T
Canonical exit: 12 Mar 2026 (T+90)
10,000 shares@ SGD 0.3550.1% of flowShareSGX-STISIN SG1EE4000006SGX:IILKB7IR2VQ1FYF8
Canonical exit: 19 Jan 2026 (T+90)
100,000 shares@ SGD 0.2851.0% of flowShareSGX-STISIN SG1EE4000006SGX:45K0DFO7JR8SR1QW
Canonical exit: 11 Aug 2025 (T+90)
88,000 shares@ SGD 0.2850.8% of flowShareSGX-STISIN SG1EE4000006SGX:RE28LOGBVGO0DU7A
Canonical exit: 16 Jul 2025 (T+90)
3,000 shares@ SGD 0.290.0% of flowShareSGX-STISIN SG1EE4000006SGX:3FV0FEO4KJKSIQC6
Canonical exit: 16 Jun 2025 (T+90)
44,000 shares@ SGD 0.2950.5% of flowShareSGX-STISIN SG1EE4000006SGX:958E8OFP6RY5ZNNR
Canonical exit: 27 May 2025 (T+90)
65,000 shares@ SGD 0.275100.0% of flowShareSGX-STISIN SG1EE4000006SGX:AXTM2CMHQ36C80T0
Canonical exit: 17 Jul 2024 (T+90)
32,000 shares@ SGD 0.2750.3% of flowShareSGX-STISIN SG1EE4000006SGX:QJ9KZSAFH5H2R4RL
Canonical exit: 30 Jun 2024 (T+90)
20,000 shares@ SGD 0.2817.1% of flowShareSGX-STISIN SG1EE4000006SGX:LGHYOG842GIZMXKS
Canonical exit: 30 May 2024 (T+90)
ShareSGX-STISIN SG1EE4000006SGX:NVA47FNPIQLGBTVC
38,045,560 shares@ SGD 0.28100.0% of flowShareSGX-STISIN SG1EE4000006SGX:QXCZJVTJ32UOP3NT
10,222,958 shares@ SGD 0.2895.0% of flowShareSGX-STISIN SG1EE4000006SGX:GCPUEWXI1NKRSVA8
Canonical exit: 17 Oct 2023 (T+90)
27,822,602 shares@ SGD 0.2897.7% of flowShareSGX-STISIN SG1EE4000006SGX:58DQR1XMAT9EIBYN
Canonical exit: 17 Oct 2023 (T+90)
27,822,602 shares@ SGD 0.28100.0% of flowShareSGX-STISIN SG1EE4000006SGX:W7ZVYEQ0JCB26BJD
Canonical exit: 17 Oct 2023 (T+90)
25 of 44 declarations
About Hyphens Pharma International Limited
Hyphens Pharma International Limited is a company active in the pharmaceutical sector, specializing in the distribution of healthcare products. It is listed on the Singapore Exchange Securities Trading Limited (XSES).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
